gefitinib has been researched along with isoguvacine in 1 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (isoguvacine) | Trials (isoguvacine) | Recent Studies (post-2010) (isoguvacine) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 178 | 0 | 30 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brame, LS; Cao, A; Fang, YT; Fung, KM; Humphreys, MR; Kropp, BP; Lin, HK; Shih, PT; Wu, W; Yang, Q | 1 |
1 other study(ies) available for gefitinib and isoguvacine
Article | Year |
---|---|
Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer.
Topics: Autocrine Communication; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Isonicotinic Acids; Male; Paracrine Communication; Phosphorylation; Picrotoxin; Prostate; Prostatic Neoplasms; Protein Kinase Inhibitors; Quinazolines; Receptors, GABA-A; Signal Transduction; src-Family Kinases | 2014 |